News

For weight loss, weight management, and overall wellness, focus on eating healthy foods, like high-protein meals, legumes, ...
The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten with a federal deadline to halt off-brand products.
Access to Medicine Foundation report highlights barriers to insulin access for children with type 1 diabetes in low-income ...
A new head-to-head study reveals tirzepatide achieves 47% more weight loss than semaglutide in people with obesity but without diabetes, highlighting its superior effectiveness and cardiometabolic ...
Weight loss injections could be available in Northern Ireland on the health service, after the first regional obesity ...
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
The FDA has approved medications like Zepbound and Wegovy for weight loss, which use the same active ingredient as the ...
Omada Health is launching new AI tools for nutrition care after filing its S-1 to go public.
Ozempic, a prescription drug typically used to manage type 2 diabetes, is fast turning into an answer for quick weight loss ...
You’ve likely heard the hype around Ozempic and Wegovy – weight loss drugs that have taken the world by storm. These ...
Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...